Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Conference Papers

Haile DC; Diouf I; Ozakbas S; Horakova D; Havrdova EK; Patti F; Eichau S; Alroughani R; Lugaresi A; Tomassini V; Prat A; Girard M; Terzi M; Yamout B; Khoury SJ; Grammond P; Blanco Y; Shaygannejad V; Foschi M; Surcinelli A; Neri S; Weinstock-Guttman B; Prevost J; Amato MP; Barnett M; Gerlach O; John N; Kermode AG; Fabis-Pedrini M; Carroll WM; van der Walt A; Butzkueven H; van Pesch V; Soysal A; Gouider R; Mrabet S; Spitaleri D; Cartechini E; Maimone D; Ampapa R; Laureys G; Ramo-Tello C; Di Gregorio M; Lapointe E; Slee M; Karabudak R; Garber J; Altintas A; Hodgkinson S; Sanchez-Menoyo JL; Castillo-Triviño T; Habek M; Al-Asmi A; Al-Harbi T; Csepany T; Cárdenas-Robledo S; Taylor B; Foong YC; Willekens B; Shalaby N; Moore F; McGuigan C; Baghbanian SM; Massey J; Hardy TA; Ramanathan S; Gross-Paju K; Gray O; Decoo D; Shaw C; Simu M; Rozsa C; Stuart EA; Sharmin S; Roos I; Kalincik T, 2026, 'Causal effects of multiple sclerosis therapies in left-truncated registry data', in Multiple Sclerosis Journal, SAGE Publications, pp. 1052 - 1068, http://dx.doi.org/10.1177/13524585261459943

Hoepner R; Bleher ABA; Wagner T; Bietiger-Badea A; Kilaru A; Bhad P; Stangel M; Massey J, 2025, 'Study Design of Two Phase 1/2 Studies to Assess Safety and Efficacy of YTB323, an Autologous CD19-Directed CAR-T Cell Therapy, in Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, pp. 1162 - 1162, presented at 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 24 September 2025 - 26 September 2025

Visweswaran M; Massey JC; Khoo ML; Withers B; Zaunders JJ; Ma D; Moore J, 2025, 'CHARACTERISATION OF IMMUNOMETABOLIC PROFILE AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEOPLE WITH MULTIPLE SCLEROSIS', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, ELECTR NETWORK, pp. 44 - 44, presented at 51st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 30 March 2025 - 02 April 2025

Ma D; Massey J; Penglase R; Artuz CM; Tao H; Adams R; Wittert G; Moore J; Molloy T, 2025, 'CLONAL HAEMATOPOIESIS IN PATIENTS WITH AUTOIMMUNE DISEASE UNDERGOING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, ELECTR NETWORK, pp. 43 - 44, presented at 51st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 30 March 2025 - 02 April 2025

Yin J; Kaakoush NO; Massey J; Danta M, 2025, 'Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis', in Frontiers in Immunology, http://dx.doi.org/10.3389/fimmu.2025.1590601

Daruwalla C; Kremler C; Patti F; Libertínová J; Ozakbas S; Peterka M; Vachova M; Boz C; Scott JL; Roos I; Foschi M; Surcinelli A; Neri S; Khoury S; Walt AVD; Butzkueven H; Meca-Lallana JE; Rous Z; Habek M; Alroughani R; Grammond P; Blanco Y; Laureys G; Buzzard K; Skibina O; Gray O; McCombe P; Ayuso GI; Eichau S; Spitaleri DL; Maimone D; Prat A; Girard M; Duquette P; Sanchez JL; Pesch VV; Oh J; Soysal A; Amato MP; Wijmeersch BV; Gerlach O; Lugaresi A; Tomassini V; Hodgkinson S; Hradilek P; Dufek M; Messina S; Taylor B; Foong YC; Cárdenas-Robledo S; Cartechini E; John NA; MacDonell R; D’amico E; Willekens B; Garber J; Terzi M; Massey J; Houskova J; Lapointe E; Stetkarova I; Al-Asmi A; Barnett M; Slee M; Guimaraes J; Csépány T; Gouider R; Mrabet S; Yammout B; Kuhle J; Gross-Paju K; Castillo-Triviño T; Kerrigan S; Tolkovsky A; Madley-Dowd P; Coles A; Sterne J; Kalincik T; Brown W, 2025, '247 Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation', BMJ, pp. a76.3 - a7a77, presented at 247 Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation, http://dx.doi.org/10.1136/jnnp-2025-abn.247

Schneider-Hohendorf T; Wuensch C; Falk S; Raposo C; Rubelt F; Mirebrahim H; Asgharian H; Schlecht U; Mattox D; Wenyu Z; Dawin E; Pawlitzki M; Lauks S; Jarius S; Wildemann B; Havla J; Kumpfel T; Schrot M-C; Ringelstein M; Kramer M; Schwake C; Schmitter T; Ayzenberg I; Fischer K; Meuth S; Aktas O; Huemmert MW; Kretschmer J; Trebst C; Kleffner I; Massey J; Muraro P; Chen-Harris H; Gross CC; Klotz L; Wiendl H; Schwab N, 2024, 'Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 1142 - 1143, presented at 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), DENMARK, Copenhagen, 18 September 2024 - 20 September 2024

Daruwalla C; Kremler C; Adesoye G; Patti F; Ozakbas S; Boz C; Lechner-Scott J; Yamout BI; Khoury S; van der Walt A; Butzkueven H; Foschi M; Surcinelli A; Alroughani R; Spitaleri DLA; Ayuso GI; Madueno SE; Buzzard K; Skibina O; Grammond P; Blanco Y; Laureys G; Van Hijfte L; Sanchez JL; Maimone D; Mccombe P; Van Pesch V; Oh J; Gray O; Soysal A; Prat A; Girard M; Duquette P; Amato MP; Van Wijmeersch B; Lugaresi A; De Luca G; Tomassini V; Habek M; Cartechini E; Gerlach O; Taylor B; Willekens B; Massey J; Garber J; Gouider R; Mrabet S; Terzi M; Rio M; Sa MJ; Csepany T; Macdonell R; McGuigan C; Al-Asmi A; Madley-Dowd P; Sterne J; Roos I; Coles A; Kalincik T; Brown JWL, 2024, 'Clinically silent MRI lesions are associated with subsequent relapses and disability worsening in treated people with RRMS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 634 - 637, presented at 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), DENMARK, Copenhagen, 18 September 2024 - 20 September 2024

Kalincik T; Sharmin S; Roos I; Freedman MS; Atkins H; Massey J; Sutton I; Withers B; Burman J; Torkildsen O; Bo L; Lehmann AK; Havrdova E; Krasulova E; Trneny M; Kozak T; Macdonell R; Brown W; Coles A; Van der Walt A; Butzkueven H; Van Wijmeersch B; Lechner-Scott J; Barnett M; Laureys G; Van Hijfte L; Willekens B; Buzzard K; Skibina O; Di Gregorio M; Hodgkinson S; Ozakbas S; Lallana JM; Alroughani R; Prevost J; Foschi M; Surcinelli A; Neri S; Ayuso GI; Eichau S; Mccombe P; John NA; Boz C; Cardenas-Robledo S; Oh J; Sanchez JL; Patti F; Gerlach O; Blanco Y; Grammond P; Sharrack B; Snowden J, 2024, 'Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 1193 - 1196, presented at 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), DENMARK, Copenhagen, 18 September 2024 - 20 September 2024

Saccardi R; Ponzano M; Badoglio M; Helbig G; Smilowsky M; Mariottini A; Burman J; Carlson K; Kazmi M; Muraro P; Apperley J; Withers B; Massey J; Varaldo R; Inglese M; Sanz J; Gil-Perotin SG; Sharrack B; Alexander T; Greco R; Snowden J, 2024, 'BEAM/ATG OR CYCLOPHOSPHAMIDE/ATG AS CONDITIONING REGIMEN IN AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE SCLEROSIS: A RETROSPECTIVE ANALYSIS OF THE EBMT AUTOIMMUNE DISEASES WORKING PARTY', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, SCOTLAND, Glasgow, pp. 41 - 41, presented at 50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), SCOTLAND, Glasgow, 14 April 2024 - 17 April 2024

Khoo M; Ford C; Massey J; Hendrawan K; Visweswaran M; Zaunders J; Sutton I; Withers B; Ma D; Moore J, 2024, 'LONG TERM PERSISTENCE OF T MEMORY STEM CELLS FOLLOWING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE SCLEROSIS', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, SCOTLAND, Glasgow, pp. 192 - 193, presented at 50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), SCOTLAND, Glasgow, 14 April 2024 - 17 April 2024

Kean S; Massey J; Jude M; Silsby M, 2024, '3133 Ocrelizumab and inflammatory bowel disease', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A42.2 - A42, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.118

Sharmin S; Roos I; Simpson-Yap S; Malpas C; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Kermode A; Butler E; Barnett M; Hodgkinson S; McCombe P; Taylor B; Slee M; Macdonell R; Garber J; Shaw C; Shuey N; Massey J; Hardy T; Parratt J; Kalincik T, 2023, 'The risk of secondary progressive multiple sclerosis is geographically determined but modifiable', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Perth, pp. 6 - 6, presented at Multiple Sclerosis Australia: Progress in MS Research Conference (MS), AUSTRALIA, Perth, 29 November 2023 - 01 December 2023

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Moore J; Ma D; Sutton I, 2023, 'EBV-specific T cells are enriched following Autologous Stem Cell Transplant for MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ITALY, Milan, pp. 41 - 41, presented at 9th Joint ECTRIMS-ACTRIMS meeting, ITALY, Milan, 11 October 2023 - 13 October 2023

Dyer Z; Massey J; Sutton I; Jackson K; Moore J; Ma D; Penglase R; Visweswaran M; Khoo M; Singh M; Withers B, 2023, 'The production of new regulatory T cell clones is associated with clinical response following autologous haematopoietic stem cell transplant for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ITALY, Milan, pp. 809 - 809, presented at 9th Joint ECTRIMS-ACTRIMS meeting, ITALY, Milan, 11 October 2023 - 13 October 2023

Moore J; Milliken S; Withers B; Massey J; Sutton I; Penglase R; Englert H; Laila G; Handel M; Brooks P; Jabbour A; Eugene K; Karki N; Horne A; Tao H; Snowden J; Biggs J; Ma D, 2023, 'AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES AT ST VINCENTS HOSPITAL, SYDNEY-25 YEARS AND 159 PATIENTS: AN ANALYSIS OF DISEASE SPECIFIC OUTCOMES AND SAFETY', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, ELECTR NETWORK, pp. 37 - 38, presented at 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 April 2023 - 26 April 2023

Massey J; Nitz C; Moore J; Ma D; Withers B, 2023, '13 Autologous haematopoietic Stem cell transplantation for non-MS neuroimmunological disorders: a single centre experience', in Concurrent Session Abstracts, BMJ Publishing Group Ltd, pp. A6.3 - A6, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.14

Massey J; Dyer Z; Sutton I; Moore J; Ma D, 2023, '5 AHSCT as immune reconstitution therapy for MS – resetting the immune system or depleting EBV reservoirs?', in Young Investigators Presentation Abstracts, BMJ Publishing Group Ltd, pp. A2.2 - A2, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.5

Massey J; Jackson K; Singh M; Hughes B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Long-term Immune Reconstitution after Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 29 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalincik T; Sharman S; Roos I; Freedman M; Atkins H; Burman J; Massey J; Sutton I; Withers B; Macdonell R; Grigg A; Torkildsen O; Bo L; Lehmann A; Horakova D; Havrdova E; Krasulova E; Trneny M; Kozak T; van der Walt A; Butzkueven H; McCombe P; Van Wijmeersch B; Buzzard K; Skibina O; Lechner-Scott J; Willekens B; Barnett M; Cartechini E; Ozakbas S; Alroughani R; Izquierdo G; Eichau S; Boz C; Kuhle J; Patti F; Terzi M; Prat A; Girard M; Duquette P; Grammond P; Onofrj M; Lugaresi A; Khoury S; Soysal A; Slee M; Prevost J; Turkoglu R; Sharrack B; Snowden J, 2022, 'Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, NETHERLANDS, Amsterdam, pp. 11 - 14, presented at 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, NETHERLANDS, Amsterdam, 26 October 2022 - 28 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalincik T; Sharmin S; Roos I; Freedman MS; Atkins H; Burman J; Massey J; Sutton I; Withers B; Macdonell R; Grigg A; Torkildsen O; Bo L; Lehmann AK; Horakova D; Havrdova EK; Krasulova E; Trneny M; Kozak T; van der Walt A; Butzkueven H; Van Wijmeersch B; McCombe P; Buzzard K; Skibina O; Lechner-Scott J; Willekens B; Barnett M; Cartechini E; Izquierdo G; Eichau S; Patti F; Hodgkinson S; Prevost J; Onofrj M; Lugaresi A; Alroughani R; Butler E; Prat A; Girard M; Duquette P; Grammond P; Grand'Maison F; Laureys G; Van Hijfte L; Maimone D; Sharrack B; Snowden J, 2022, 'Comparative effectiveness of autologous haematopoietic stem cell transplantation with immune reconstitution therapies in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, NETHERLANDS, Amsterdam, pp. 619 - 621, presented at 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, NETHERLANDS, Amsterdam, 26 October 2022 - 28 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540802298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalincik T; Sharmin S; Roos I; Massey J; Sutton I; Withers B; Freedman M; Atkins H; Horakova D; Havrdova EK; Krasulova E; Trneny M; Kozak T; Burman J; Macdonell R; Grigg A; Torkildsen O; Bo L; Lehmann AK; Sharrack B; Snowden J, 2022, 'Effectiveness of autologous haematopoietic stem cell transplantation in comparison with natalizumab in progressive MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, NETHERLANDS, Amsterdam, pp. 953 - 954, presented at 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, NETHERLANDS, Amsterdam, 26 October 2022 - 28 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540803426&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J; Jackson K; Singh M; Hughes B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 20 - 20, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899138300042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Long-term Immune Reconstitution after Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 29 - 29, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899138300064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J; Jackson K; Singh M; Cheynier R; Moore J; Ma D; Sutton I, 2022, '2314 Extensive remodelling of the lymphocyte repertoire and deletion of autoreactive clones following AHSCT in MS', in Abstracts, BMJ Publishing Group Ltd, pp. A11.2 - A11, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.28

Fontes-Villalba A; Boyle T; Fernando S; Massey J; Parratt J, 2022, '2459 Acute plexitis after AstraZeneca COVID-19 vaccination in two immunocompromised patients', in Abstracts, BMJ Publishing Group Ltd, pp. A67.2 - A67, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.183

Bryan B; Invina-Hernandez J; Massey J; Redwine J; Armitage J, 2022, 'The Biolinked Registry: Connection Is the Key to Innovation', in TRANSFUSION, WILEY, pp. 167A - 167A

Massey J, 2019, 'Diversification of the T cell repertoire following AHSCT is underpinned by thymic derived naive T cells in patients with aggressive RRMS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, pp. NP17 - NP17, presented at Conference of MS-Research-Australia, AUSTRALIA, Melbourne, 31 October 2019 - 01 November 2019

Massey J; Ford C; Khoo M; Cheynier R; Charmantu B; Zaunders J; Hendrawan K; Sutton I; Withers B; Milliken S; Ma D; Moore J, 2019, 'Immune reconstitution following autologous haematopoietic stem cell transplantation for multiple sclerosis is driven by sustained thymic reactivation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GERMANY, Frankfurt, pp. 32 - 33, presented at 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), GERMANY, Frankfurt, 24 March 2019 - 27 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487707800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ford CD; Khoo M; Zaunders J; Massey J; Hendrawan K; Sutton I; Ma DDF; Moore JJ, 2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702802073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J; Moore J; Sutton I; Ma CKK; Milliken S; Ma D, 2017, 'Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) - a Phase II Clinical Trial', in BLOOD, AMER SOC HEMATOLOGY, GA, Atlanta, presented at 59th Annual Meeting of the American-Society-of-Hematology (ASH), GA, Atlanta, 09 December 2017 - 12 December 2017

Massey J, 2017, 'Autologous haematopoietic stem cell transplantation (AHSCT) in relapse remitting (RR-MS) and secondary progressive multiple sclerosis (SP-MS): a phase II trial from St Vincent's Hospital, Sydney Australia', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 594 - 594, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017

Massey J; Sutton I; Ma K; Miliken S; Ma D; Moore J, 2017, 'Autologous haematopoietic stem cell transplantation (aHSCT) in multiple sclerosis (MS) a phase II trial at St Vincent's Hospital, Sydney', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP6 - NP6, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J, 2017, 'Histopathological neurosarcoidosis in response to disseminated seminoma with absence of central nervous system metastases', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS

Moore J; Ma K; Sutton I; Milliken S; Ma D; Massey J, 2017, 'Autologous stem cell transplantation (ASCT) in relapse remitting (RR-MS) and secondary progressive multiple sclerosis (SP-MS): an Australian-based prospective phase II trial', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, FRANCE, Marseille, pp. S43 - S44, presented at 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), FRANCE, Marseille, 26 March 2017 - 29 March 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424355300048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page